- Home
- AMPY vs SCPH Comparison
AMPY vs SCPH Comparison
Compare AMPY & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPY
- SCPH
- Stock Information
- Founded
- AMPY 2011
- SCPH 2013
- Country
- AMPY United States
- SCPH United States
- Employees
- AMPY N/A
- SCPH N/A
- Industry
- AMPY Oil & Gas Production
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- AMPY Energy
- SCPH Health Care
- Exchange
- AMPY Nasdaq
- SCPH Nasdaq
- Market Cap
- AMPY 261.9M
- SCPH 274.7M
- IPO Year
- AMPY 2011
- SCPH 2017
- Fundamental
- Price
- AMPY $6.56
- SCPH $4.42
- Analyst Decision
- AMPY Strong Buy
- SCPH Strong Buy
- Analyst Count
- AMPY 3
- SCPH 1
- Target Price
- AMPY $10.00
- SCPH $18.00
- AVG Volume (30 Days)
- AMPY 275.3K
- SCPH 292.9K
- Earning Date
- AMPY 11-04-2024
- SCPH 11-06-2024
- Dividend Yield
- AMPY N/A
- SCPH N/A
- EPS Growth
- AMPY N/A
- SCPH N/A
- EPS
- AMPY 0.68
- SCPH N/A
- Revenue
- AMPY $311,557,000.00
- SCPH $24,048,000.00
- Revenue This Year
- AMPY $12.38
- SCPH $195.62
- Revenue Next Year
- AMPY $3.41
- SCPH $145.07
- P/E Ratio
- AMPY $9.63
- SCPH N/A
- Revenue Growth
- AMPY 0.83
- SCPH 549.77
- 52 Week Low
- AMPY $3.56
- SCPH $3.24
- 52 Week High
- AMPY $8.15
- SCPH $6.71
- Technical
- Relative Strength Index (RSI)
- AMPY 44.37
- SCPH 47.49
- Support Level
- AMPY $6.55
- SCPH $3.81
- Resistance Level
- AMPY $7.08
- SCPH $4.50
- Average True Range (ATR)
- AMPY 0.19
- SCPH 0.22
- MACD
- AMPY -0.04
- SCPH 0.05
- Stochastic Oscillator
- AMPY 7.56
- SCPH 79.22
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana, and Eagle Ford.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.